Pfizer’s booster shot has the green light from the FDA, but there are still a few hurdles it must go through before people can get it.
Search / 279 results found Showing: 1-10 of 279
Next week, the Biden Administration was hoping to roll out booster shots for the public, but now it seems that won't be happening.
Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer's vaccine six months after full vaccination in people 65 and older and those at high risk of severe COVID-19.
NASHVILLE (WSMV) - The FDA is now reviewing an application submitted by Pfizer in regards to receiving a third dose of the vaccine to help con…
Last December, when advisers to the US Food and Drug Administration met to consider whether the agency should authorize Pfizer's Covid-19 vaccine, it was generally understood that the answer would be yes.
COVID-19 infections have risen "exponentially" among children in the US since July, according to data published Monday by the American Academy of Pediatrics (AAP).
Health experts predict Pfizer may have a vaccine ready for young children by the end of October, under a best-case scenario.
Millions of Americans still need to get vaccinated to slow or stop the spread of Covid-19 and getting the pandemic under control could take "many, many" more vaccine mandates, Dr. Anthony Fauci said.
Former President Donald Trump said he “isn’t against” a COVID-19 booster shot but that he “probably won’t” get one if the US authorizes it for use among most Americans.
There have been internal conversations within the Biden administration about scaling back the ambitious booster plan laid out by top federal health officials last month as the calendar nears September 20, the date when booster shots may start to be offered.